Tamsin Cargill
DPhil student
Brief biography:
I have been working with the Barnes group alongside my clinical training for several years. Much of my work has been focused on translational cellular immunology in immune mediated hepatobiliary disease. Recently I have been awarded a Welcome Trust Clinical Fellowship to undertake a PhD on HBV immunotherapy within the vaccine group.
Research Interests:
I am interested in harnessing cellular immunology to understand disease pathogenesis and develop novel treatment strategies for hepatobiliary conditions.
Current projects:
IgG4-Related Disease Study: Natural history and pathogenesis
Immunotherapy for chronic Hepatitis B infection
Recent publications
Hepatology at home: a novel pathway for the integrated management of patients with liver disease in the home
Journal article
Cargill T. et al, (2025), FRONTLINE GASTROENTEROLOGY
The Differential Complement, Fc and Chemokine Receptor Expression of B Cells in IgG4-Related Pancreatobiliary Disease and Primary Sclerosing Cholangitis and Its Relevance for Targeting B Cell Pathways in Disease
Journal article
Cargill T. et al, (2024), Biomedicines, 12, 2839 - 2839
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
Journal article
Davis C. et al, (2024), Vaccines, 12, 644 - 644
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
Journal article
Cargill T. et al, (2023), JHEP Reports, 5, 100885 - 100885
NK cells limit therapeutic vaccine–induced CD8 + T cell immunity in a PD-L1–dependent manner
Journal article
Diniz MO. et al, (2022), Science Translational Medicine, 14
